Author:
Wu Chung-Chun,Fang Chih-Yeu,Cheng Yu-Jhen,Hsu Hui-Yu,Chou Sheng-Ping,Huang Sheng-Yen,Tsai Ching-Hwa,Chen Jen-Yang
Funder
National Science Council
Ministry of Science and Technology, Taiwan
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Biochemistry (medical),Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine,Endocrinology, Diabetes and Metabolism
Reference60 articles.
1. Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM, editors. Field’s Virology. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 2575–627.
2. Henle W, Henle G. Evidence for an etiologic relation of the Epstein-Barr virus to human malignancies. The Laryngoscope. 1977;87:467–73.
3. Ling W, Cao SM, Huang QH, Li YH, Deng MQ. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong. Ai Zheng. 2009;28:57–9.
4. Asito AS, Piriou E, Odada PS, Fiore N, Middeldorp JM, Long C, Dutta S, Lanar DE, Jura WG, Ouma C, Otieno JA, Moormann AM, Rochford R. Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt’s lymphoma patients: a case control study. Infect Agent Cancer. 2010;5:13.
5. Chen JY, Hwang LY, Beasley RP, Chien CS, Yang CS. Antibody response to Epstein-Barr-virus-specific DNase in 13 patients with nasopharyngeal carcinoma in Taiwan: a retrospective study. Journal of medical virology. 1985;16:99–105.
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献